Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,076 public trials 1,849 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

NCT04177953

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin Berlin, Germany
  • Klinikum Bremen Ost Pneumologie und Beatmungsmedizin Bremen, Germany
  • Studienzentrum der Thorachirurgischen und Pneumologischen Klinik Klinken der Stadt Köln gGmbH Krankenhaus Merheim Cologne, Germany
  • Ev. Kliniken Essen-Mitte, Klinik für Internistische Onkologie Essen, Germany
View Trial Details
Completed

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer

NCT03663205

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
View all 47 locations
View Trial Details
Completed

An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network

NCT04564079

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre hospitalier universitaire Dr-Georges-L.-Dumont Moncton, New Brunswick, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

Avelumab in First-line NSCLC (JAVELIN Lung 100)

NCT02576574

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Arizona Center for Cancer Care Surprise, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University Cancer Institute Boynton Beach, Florida, United States
View all 349 locations
View Trial Details
Completed

Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies

NCT03447470

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Cancer, +9 more
Locations
  • Royal Marsden Hospital, Institute of Cancer Research Sutton, Surrey, United Kingdom
  • Guys Hospital London, United Kingdom
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • Sir Bobby Robson Cancer Trials Research Centre Newcastle, United Kingdom
View Trial Details
Completed

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

NCT03821233

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +44 more
Locations
  • City of Hope Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 16 locations
View Trial Details

Related conditions